Workflow
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
JNJJ&J(JNJ) The Motley Fool·2025-02-24 12:30

Core Insights - Medtronic and Johnson & Johnson are highlighted as strong dividend-paying stocks with healthy financial profiles, making them attractive for investors seeking reliable income streams [1][12] Medtronic - Medtronic offers a dividend yield of 3.1%, significantly higher than the S&P 500's 1.2%, translating to 3.10individendsper3.10 in dividends per 100 invested compared to 1.20 for the S&P 500 [2] - The company generated 4.5 billion in net cash from operating activities in the first nine months of the year, with 3.1billioninfreecashflowafterinvesting3.1 billion in free cash flow after investing 1.4 billion in capital expenditures, easily covering 2.6billionindividends[3]Medtronicrepurchasednearly2.6 billion in dividends [3] - Medtronic repurchased nearly 3 billion of its stock and has a strong balance sheet with A/A3 bond ratings, allowing for potential acquisitions [4] - The company has a history of increasing dividends for 47 consecutive years at a compound annual growth rate of 16% [5] - Expected organic revenue growth of about 5% this fiscal year, with a robust pipeline of product approvals, indicates continued growth potential [6] Johnson & Johnson - Johnson & Johnson also offers a 3.1% dividend yield, supported by a strong financial profile and an AAA bond rating, one of the highest globally [7][8] - The company has a market cap of nearly 400billion,withonly400 billion, with only 12 billion in net debt and generates approximately 20billioninfreecashflowannually,coveringits20 billion in free cash flow annually, covering its 11.8 billion dividend payments [8] - Johnson & Johnson has committed 32billiontostrategicacquisitionsoverthepastyear,includinga32 billion to strategic acquisitions over the past year, including a 14.6 billion deal for Inter-Cellular Therapies, enhancing its product portfolio [9] - The company has increased its dividend for 62 consecutive years, placing it among the elite Dividend Kings [10] Conclusion - Both Medtronic and Johnson & Johnson exhibit strong cash generation and financial flexibility, positioning them well for sustained dividend growth and long-term investment appeal [12]